Medicines from India: Registered Pharmaceutical Sourcing and Export Enquiries

Medicines from India should be sourced through an appropriately authorised supply chain for the destination market. Packaged medicaments, bulk pharmaceutical products, antibiotics and temperature-sensitive biological medicines have different procurement and registration requirements. Wigmore Trading can discuss a compliant commercial enquiry without implying that every product is available or approved.

Confirm market authorisation before purchasing

Verify the manufacturer, manufacturing site and product-specific approvals with the relevant authorities. Establish whether a valid registration, import permit or another route is required. Some products can be restricted even when similar medicines are widely sold.

India’s pharmaceutical export procedures and destination rules must both be satisfied. Refer to CDSCO and the destination medicines regulator for current product-specific requirements. An exporter’s general licence or a product’s domestic availability does not automatically authorise import or distribution elsewhere.

Packaged and unpackaged products are different enquiries

Finished retail packs need approved labelling, patient information where applicable, batch identification and shelf-life requirements. Bulk or unpackaged material requires an authorised manufacturing or processing use and appropriate quality documentation. It should not be treated as ready for direct patient supply.

For antibiotics, procurement must follow the destination’s prescription and distribution rules. This page provides business procurement considerations, not treatment advice or a route around professional controls.

Quality and traceability

Agree product specifications, relevant quality evidence, batch documentation and the minimum remaining shelf life at delivery. Verify documents with their issuers where needed. Inspection and testing should be planned by qualified pharmaceutical-quality personnel.

Maintain the chain between the manufacturer, exporter, importer and recipient. Record how complaints, suspected falsification, recalls and rejected stock are handled. A certificate of analysis does not replace product registration or an authorised supply chain.

Vaccines, antisera and other sensitive products

Temperature-sensitive medicines require product-specific storage, shipping qualification, monitoring and excursion procedures. Not every product uses the same temperature range. Confirm handling from collection through to the receiving facility, including delays and handover.

Requests involving biological materials, cultures or toxins require specialist identification and legal review. They are not offered as routine wholesale goods through this general enquiry guide. Only an appropriate, lawful and specifically authorised scope can be considered.

Commercial procurement brief

Send Wigmore the product details and importer information. Our team can assess sourcing and logistics requirements within an agreed scope. No medicine availability, registration, clinical effectiveness or manufacturer appointment is represented by the inclusion of a keyword.